| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹698.06 Cr |
| Fresh Issue | ₹138.00 Cr |
| Offer for Sale | ₹560.06 Cr |
| Face Value | โน2 Per Equity Share |
| Price Band | โน407.00-428.00 per share |
| Discount | Retail: 0.00,Employee: 0.00,ShareHolder: 0.00 |
| BSE Code | 544339 |
| NSE Code | LAXMIDENTL |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers | SBI Capital Markets Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 33 shares and in multiples thereof
Incorporated in July 2004, Laxmi Dental Limited is an integrated dental products company. The company offers custom crowns and bridges, branded dental items like clear aligners and thermoforming sheets, aligner-related products as part of its aligner solutions, and pediatric dental products.
Their product portfolio includes custom crowns and bridges, clear aligners, thermoforming sheets, pediatric dental products, and more.
The company offers thermoforming sheets, biocompatible 3D printing resins, and machines for manufacturing clear aligners under the brand name Taglus.
The company operate a fully integrated model, meaning they handle the entire process from design and manufacturing to distribution of dental products.
As of September 30, 2024, the company has six manufacturing facilities: three in Mira Road, Mumbai, two in Boisar, and one in Kochi, along with five supporting facilities in Mumbai, Delhi, Bengaluru, and Ahmedabad.
As of September 30, 2024, the company’s dental network includes over 22,000 clinics and dentists across more than 320 cities nationwide.
The company has significant presence in both domestic and international markets, exporting to over 90 countries.
As of September 30, 2024, the company had 2,372 employees in various departments.
Competitive strengths
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (โน Cr.) |
|---|---|---|
| 1 | Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by the Company. | 22.98 |
| 2 | Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings. | 4.60 |
| 3 | Funding the capital expenditure requirements for purchase of new machinery for the Company | 43.51 |
| 4 | Investment in the Subsidiary, Bizdent Devices Pvt.Ltd., for the capital expenditure requirements for the purchase of new machinery | 25.00 |
| 5 | General Corporate Purposes | 32.08 |
| 6 | Issue Expenses | 49.72 |
| Total | 177.89 |
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 158.22 | 134.52 | 96.54 | 102.75 |
| Total Income | 117.90 | 195.26 | 163.84 | 138.07 |
| Profit After Tax | 22.74 | 25.23 | -4.16 | -18.68 |
| NET Worth | 67.09 | 44.57 | 19.48 | 22.94 |
| Total Borrowing | 40.91 | 42.03 | 31.44 | 29.63 |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 78.78% |
| ROCE | 19.97% |
| Debt / Equity | 0.94% |
| RoNW | 78.78% |
| PAT Margin | 13.03% |
| Price to Book Value | 49.59 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 4.88 | 8.27 |
| P/E (x) | 87.77 | 51.73 |
| Promoter Holding | 46.56% | 41.7% |
| Market Cap | โน2352.38 Cr. | |